Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Adeline Petit
Observed names:
A Petit,
A. Petit,
Adeline PETIT,
PETIT, Adeline,
Petit, A.,
Petit, Adeline
show all 6
Institution:
Institut Bergonié
Observed institutions:
École Nationale Vétérinaire d'Alfort,
Université Paris-Est Créteil,
Bellvitge University Hospital,
Institut d'Investigació Biomédica de Bellvitge,
Institut Català d'Oncologia,
Hospital Del Mar,
Parc de Salut,
Institut Bergonié
show all 8
ORCID:
0009-0009-7822-5991
Observed ORCID:
0009-0009-7822-5991
OpenAlex ID:
A5111797560
Radiotherapy of cervical cancer
2021
·
C. Chargari
, K. Peignaux
, et al.
·
Cancer/Radiothérapie
·
138
Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort
2019
·
David Pasquier
, Amélie Darlix
, et al.
·
European Journal of Cancer
·
55
PDF
Evaluation of acute skin toxicity of breast radiotherapy using thermography: Results of a prospective single-centre trial
2018
·
O. Maillot
, N. Leduc
, et al.
·
Cancer/Radiothérapie
·
36
Neoadjuvant chemotherapy and radiotherapy for locally advanced breast cancer: Safety and efficacy of reverse sequence compared to standard technique?
2022
·
Mathilde Maire
, Marc Debled
, et al.
·
European Journal of Surgical Oncology
·
16
Pulsed-dose-rate brachytherapy for uterine cervix carcinoma: 10 years of experience with 226 patients at a single institution
2013
·
Adeline Petit
, Anne Floquet
, et al.
·
Brachytherapy
·
13
PDF
Radiotherapy for endometrial cancer
2021
·
C. Chargari
, K. Peignaux
, et al.
·
Cancer/Radiothérapie
·
12
5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial
2026
·
Sofia Rivera
, Robabeh Ghodssighassemabadi
, et al.
·
The Lancet
·
10
OC-0758 HypoG01:UNICANCER phase 3 trial of locoregional hypo vs normo fractionated RT in early breast cancer
2023
·
S. Rivera
, E. Karamouza
, et al.
·
Radiotherapy and Oncology
·
10
Academic Randomized Phase II Trial Assessing The Inhibitor Of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab In Combination With Chemoradiation In Locally Advanced Cervical Cancer (ATEZOLACC Trial)
2025
·
Cyrus Chargari
, Patricia Pautier
, et al.
·
International Journal of Gynecological Cancer
·
9
PDF
Biomarkers Associated with Lymph Nodal Metastasis in Endometrioid Endometrial Carcinoma
2022
·
Mathilde Mairé
, Aurélien Bourdon
, et al.
·
Cancers
·
9
PDF
Role of radiotherapy in the management of vulvar cancer: Recommendations of the French society for radiation oncology
2021
·
C. Chargari
, A. Petit
, et al.
·
Cancer/Radiothérapie
·
9
Radiotherapy and brachytherapy for cervical cancer: Recommendations of the Société française de radiothérapie oncologique
2025
·
Cyrus Chargari
, Anne Ducassou
, et al.
·
Cancer/Radiothérapie
·
8
Heart is a heavy burden: cardiac toxicity in radiation oncology
2024
·
Pierre Pouvreau
, Imed Taleb
, et al.
·
Supportive Care in Cancer
·
8
Pelvic insufficiency fractures after intensity modulated radiation therapy combined with chemotherapy for cervix carcinoma: Incidence and impact of bone mineral density
2023
·
Agathe Duranson
, Vincent Thevenet
, et al.
·
Clinical and Translational Radiation Oncology
·
8
PDF
Role of radiotherapy in the treatment of primary vaginal cancer: Recommendations of the French society for radiation oncology
2021
·
C. Chargari
, K. Peignaux
, et al.
·
Cancer/Radiothérapie
·
8
Economic evaluation and budget-impact of accelerated partial breast irradiation (APBI) versus standard or hypofractionated whole breast irradiation (WBI) in postmenopausal women with early-stage breast cancer. Results from the French SHARE randomized trial
2023
·
Alicia Le Bras
, Yazid Belkacemi
, et al.
·
Radiotherapy and Oncology
·
6
Évolution des pratiques médicales d’hypofractionnement en radiothérapie pour cancer du sein et impact économique
2016
·
C. Dupin
, F. Vilotte
, et al.
·
Cancer/Radiothérapie
·
6
Comprehensive radiotherapy quality assurance analysis from individual DICOM data in the HypoG-01 phase 3 trial
2025
·
Thomas Brion
, Mamadou Balde
, et al.
·
Radiotherapy and Oncology
·
5
Radiothérapie adaptative en routine : point de vue de l’oncologue radiothérapeute
2015
·
B. Henriques de Figueiredo
, A. Petit
, et al.
·
Cancer/Radiothérapie
·
5
Use of FDG-PET to guide dose prescription heterogeneity in stereotactic body radiation therapy for lung cancers with volumetric modulated arc therapy: a feasibility study
2014
·
Bénédicte Henriques de Figueiredo
, Mikael Antoine
, et al.
·
Radiation Oncology
·
4
PDF
Adenoid Cystic Carcinoma of the Breast and Adjuvant Radiation Therapy
2025
·
Imed Taleb
, Sarah Witmeyer
, et al.
·
American Journal of Clinical Oncology
·
3
Cancers de l’endomètre de stades avancés : chirurgie première ou chimiothérapie néoadjuvante ?
2012
·
Frédéric Guyon
, Eberhard Stoeckle
, et al.
·
Bulletin du Cancer
·
3
Radiotherapy for endometrial cancer: 2025 update
2025
·
Cyrus Chargari
, Anne Ducassou
, et al.
·
Cancer/Radiothérapie
·
2
1201 Intraoperative radiotherapy in elderly patients with breast cancer: long-term follow-up results of the prospective phase II trial TARGIT-E
2025
·
Elena Sperk
, Claire Lemanski
, et al.
·
Radiotherapy and Oncology
·
2
Optimisation de la curiethérapie utérovaginale de débit pulsé des cancers du col utérin localement évolués : résultats finaux du PHRC Tridicol
2021
·
C. Charra-Brunaud
, J. Salleron
, et al.
·
Cancer/Radiothérapie
·
2
Show more works
View as search
Works count:
59
Citation count:
397
H-index:
9
I10-index:
8
Year
Topic
Type
